Jennifer Stacey
Net worth: 352 961 $ as of 2026-05-30
Net worth: 352 961 $ as of 2026-05-30
Jennifer Evans Stacey is currently an Independent Director at Context Therapeutics LLC and Context Therapeutics, Inc. since 2021.
Ms. Stacey is also Secretary, Chief Legal & Compliance Officer at Neogen Corp.
starting in 2026.
Former roles include Secretary, Chief Legal & Compliance Officer at Galera Therapeutics, Inc. from 2021 to 2024; Secretary, SVP-Human Resources & General Counsel at Antares Pharma, Inc. from 2014 to 2015; Secretary, Executive VP & General Counsel at Auxilium Pharmaceuticals LLC from 2011 to 2012; Secretary, Senior Vice President & General Counsel at FXI Holdings, Inc. from 2012 to 2014; Secretary & Senior VP-Corporate Communications at Aventis Behring LLC in 2004; Principal at Rhone-Poulenc Rorer, Inc.; Associate-Corporate Finance Department at King & Spalding LLP; and Secretary, VP & Head-Government Relations at The Wistar Institute.
Education includes an undergraduate degree from Princeton University conferred in 1986 and a graduate degree from The University of Pennsylvania Law School conferred in 1989.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
NEOGEN CORP 0.02% | 2026-04-30 | 39,349 ( 0.02% ) | 352 961 $ | 2026-05-30 |
| 2026-04-12 | 0 ( -.--% ) | - $ | 2026-05-30 |
| Companies | Position | Start |
|---|---|---|
| CONTEXT THERAPEUTICS INC. | Director/Board Member | 2021-02-28 |
| NEOGEN CORPORATION | Compliance Officer | 2026-04-07 |
Context Therapeutics LLC
Context Therapeutics LLC Pharmaceuticals: MajorHealth Technology Manufactures hormone-responsive cancer drugs | Director/Board Member | 2021-03-21 |
| Companies | Position | End |
|---|---|---|
| GALERA THERAPEUTICS, INC. | Compliance Officer | 2024-08-31 |
| ANTARES PHARMA, INC. | Human Resources Officer | 2015-07-13 |
FXI Holdings, Inc.
FXI Holdings, Inc. Industrial SpecialtiesProcess Industries Produces foam products | General Counsel | - |
| AUXILIUM PHARMACEUTICALS, INC. | Human Resources Officer | 2011-12-07 |
Aventis Behring LLC | Public Communications Contact | 2004-03-31 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 13 |
|---|---|
Neogen Corp.
Neogen Corp. Medical SpecialtiesHealth Technology Manufactures and markets medical testing kits | Health Technology |
Antares Pharma, Inc.
Antares Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops parenteral pharmaceutical products | Health Technology |
Auxilium Pharmaceuticals LLC
Auxilium Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products | Health Technology |
Galera Therapeutics, Inc.
Galera Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes drugs to reduce normal tissue toxicity from radiotherapy | Health Technology |
Rhone-Poulenc Rorer, Inc.
Rhone-Poulenc Rorer, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and markets human pharmaceuticals | Health Technology |
King & Spalding LLP
King & Spalding LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Princeton University
Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Wistar Institute
The Wistar Institute BiotechnologyHealth Technology Provides biomedical research services | Health Technology |
Aventis Behring LLC | |
FXI Holdings, Inc.
FXI Holdings, Inc. Industrial SpecialtiesProcess Industries Produces foam products | Process Industries |
The University of Pennsylvania Law School
The University of Pennsylvania Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Context Therapeutics LLC
Context Therapeutics LLC Pharmaceuticals: MajorHealth Technology Manufactures hormone-responsive cancer drugs | Health Technology |
Context Therapeutics, Inc.
Context Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which develops treatment options for women living with hormone-dependent cancer | Health Technology |
Select your edition
All financial news and data tailored to specific country editions